https://pipelinereview.com/Zentalis-Pharmaceuticals-Announces-Promising-Initial-Data-Presented-in-a-Late-Breaking-Session-at-AACR-on-ZN-c3-its-WEE1-Inhibitor-in-Patients-with-Advanced-Solid-Tumors/